Signals is a monthly intelligence briefing, created together with Neurotech Futures, that tracks the developments moving neurotechnology forward and explains why they matter. Each edition curates a small number of meaningful updates across the field, with a focus on signal over noise rather than volume.

Coverage prioritises milestones that indicate real progress, including clinical validation, regulatory movement, platform capabilities, and capital flows that shape long-term trajectories. Signals does not aim to cover daily news, press releases, or speculative research without a clear path to translation.

Each edition is structured around key developments, contextual analysis, and forward-looking signals to watch. The goal is to provide readers with a concise, strategic read that situates individual announcements within broader patterns across the neurotechnology landscape.